![Terry Bazyluk](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Terry Bazyluk
Public Communications Contact presso Association for Accessible Medicines
Posizioni attive di Terry Bazyluk
Società | Posizione | Inizio | Fine |
---|---|---|---|
Association for Accessible Medicines
![]() Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Public Communications Contact | 01/12/2014 | - |
Storia della carriera di Terry Bazyluk
Formazione di Terry Bazyluk
Harvard University | Undergraduate Degree |
Yale Law School | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Posizioni
Public Communications Contact | 1 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Settori
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Association for Accessible Medicines
![]() Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Commercial Services |
- Borsa valori
- Insiders
- Terry Bazyluk
- Esperienza